Alison Gulbis - MD Anderson Cancer Center

基本信息

Career Trajectory

Bio

Manager
Clinical Pharmacy
Medication Therapy Management
Pharmacists
Patient Safety
Clinical Research
Inpatient
Hospitals
Clinical Pharmacology
Healthcare
Oncology

Research Interests

Papers共 129 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Stay, Stay, Stay (our Version): the Value of Staying Power in Navigating the Challenges and Changes of a Career in Clinical Pharmacy

Kamakshi V Rao,Zahra Mahmoudjafari,Alison M Gulbis

American journal of health-system pharmacy AJHP official journal of the American Society of Health-System Pharmacists (2025)

Cited0Views0WOSBibtex

Enhancement of High-Dose Chemotherapy and Autologous SCT with the PARP Inhibitor Olaparib for Refractory Lymphoma

Yago Nieto,Jeremy Ramdial,Benigno Valdez,Peter F Thall,Roland Bassett,Melissa Barnett,Samer Srour,Chitra Hosing,Amin Alousi,Muzaffar Qazilbash,Uday Popat,Alison Gulbis,Terri Lynn Shigle,Sairah Ahmed,Maria Guillermo Pacheco,Richard Champlin,Elizabeth J Shpall,Borje S Andersson

Clinical cancer research an official journal of the American Association for Cancer Researchno. 6 (2025): 975-982

Cited0Views0WOSBibtex

A Comparison of Gemcitabine/Clofarabine/Busulfan (gem/clo/bu) Myeloablative Conditioning with Fludarabine/Melphalan (flu/mel) Reduced Intensity Conditioning for Allogeneic Stem-Cell Transplant (allosct) for Aggressive Lymphomas

Jeremy Ramdial,Ruitao Lin,Peter Thall,Ben C. Valdez,Chitra Hosing,Samer A. Srour,Uday R. Popat,Muzaffar H. Qazilbash,Amin M. Alousi,Elizabeth J. Shpall,Melissa Barnett, Erica Jimenez,Alison M. Gulbis,Terri Lynn Shigle,Borje S. Andersson,Yago Nieto

Transplantation and Cellular Therapyno. 2 (2024)

Cited0Views0Bibtex

Enabling Efficient Patient Discharge with a Mindset, Toolset, and Skillset Framework

Corey Russell,Kaycee Wilson,Amin Majid Alousi,Catherine Delanoix,Jennifer Freeman, Zandra R. Rivera, Nicole Brunelle, Sascha Seurattan-Smith,Alison M. Gulbis,Whitney Wallis,Marina C. George, Christopher Flowers, William G. Wierda, Elizabeth J. Shpall

JCO Oncology Practiceno. 10_suppl (2024): 33-33

Cited0Views0Bibtex

A Multistep Approach and Executive Summary Assessing and Addressing Workforce Satisfaction and Retention of the Oncology Pharmacy Workforce

Alison M. Gulbis,Zahra Mahmoudjafari,Kamakshi Rao

JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACYno. 7 (2024): 621-630

Cited0Views0Bibtex

Gemcitabine (gem) /clofarabine (clo) /busulfan (bu) (gemclobu): A New Myeloablative Conditioning Regimen with Reduced Toxicity and High Activity for Allogeneic Stem-Cell Transplant (allosct) for Aggressive Lymphomas

Jeremy Ramdial,Ben C. Valdez,Ruitao Lin,Peter Thall, Auston Wei,Chitra Hosing,Samer A. Srour,Uday R. Popat,Muzaffar H. Qazilbash,Amin M. Alousi,Melissa Barnett,Alison M. Gulbis,Terri Lynn Shigle,Elizabeth J. Shpall,Borje S. Andersson,Yago Nieto

Transplantation and Cellular Therapyno. 2 (2024): S56

Cited0Views0Bibtex

Incidence of Bacterial Blood Stream Infections in Patients with Acute GVHD

Whitney Wallis,Alison M. Gulbis,Tao Wang,Catherine J. Lee,Akshay Sharma,Kirsten M. Williams,Taiga Nishihori,Tim Prestidge,Lohith Gowda, Michael Byrne,Maxwell M. Krem,Margaret L. MacMillan,Carrie L. Kitko,Joseph Pidala,Stephen R. Spellman,Stephanie J. Lee,Amin M. Alousi

Bone Marrow Transplantationno. 1 (2024): 52-57

Cited0Views0WOSNATUREBibtex

High Activity of the New Myeloablative Regimen of Gemcitabine/clofarabine/busulfan for Allogeneic Transplant for Aggressive Lymphomas

Jeremy Ramdial,Ruitao Lin,Peter F. Thall,Benigno C. Valdez,Chitra Hosing,Samer Srour,Uday Popat,Muzaffar Qazilbash,Amin Alousi,Melissa Barnett,Alison Gulbis,Terri Lynn Shigle,Elizabeth J. Shpall,Borje S. Andersson,Yago Nieto

BONE MARROW TRANSPLANTATION (2024)

Cited0Views0WOSNATUREBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn